Ultibro Breezhaler

Ultibro Breezhaler (generic contents: indacaterol & glycopyrronium) is an inhaler that is used to relieve symptoms of chronic obstructive pulmonary disease (COPD) in adults. The term COPD applies mainly to emphysema and chronic bronchitis but can also refer to other breathing difficulties. These conditions block free airflow into the lungs and make breathing harder. Indacaterol is a long-acting beta-2 agonist (LABA) that activates receptors in the muscles of the airways to the lungs, which causes them to relax.
Glycopyrronium is a muscarinic-receptor antagonist. It controls the contraction of muscles and lets the airways expand. The combined action of these substances in Ultibro Breezhaler helps to maintain open airways, which allows the person to breathe more easily. Dosage The prescribing doctor determines the dosage and regimen. The usual dosage is inhaling one capsule daily. Ultibro is effective for 24 hours.